Bioprinting: Technologies and Global Markets

Report Highlights

The global bioprinting technologies market should reach $5.0 billion by 2027 from $2.4 billion in 2022 at a compound annual growth rate (CAGR) of 16.2% for the forecast period of 2022 to 2027.

Report Includes

• 26 data tables and 35 additional tables
• An up-to-date review and analysis of the global markets for bioprinting technologies and applications within the industry
• Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of market opportunities for this innovation-driven market, and the major regions and countries involved in market developments
• Estimation of the actual market size and revenue forecast for global bioprinting market in USD millions, and corresponding market share analysis by type of technology, application, end-user, and region
• Technology assessment of the key drivers, restraints and opportunities that will shape the market for bioprinting over the forecast period (2022 to 2027)
• Analysis of the markets for the main bioprinting end-use applications, including research, drug discovery and development, cosmetics, and clinical
• Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on technologies, applications, and end users of bioprinting
• Updated information on recent industry acquisitions, partnerships, agreements, collaborations, and other strategic alliances in the global bioprinting market
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
• Profile descriptions of the market leading participants, including 3D Bio Corp., Advanced Solutions Inc., Cellink, Organovo, and Stratasys Ltd.

Report Scope

This report incorporates an in-depth analysis of the bioprinting market, including market estimations and trends through 2020. Major players, competitive intelligence, innovative technologies, market dynamics, and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for bioprinting technologies.

The scope of the report extends to only those bioprinting technologies that generate the most global revenue. Surgical device or guides and ceramics or metal devices used in 3D bioprinting overlap with other products that are already covered under the technology segments, so these have been excluded.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World region. For market estimates, data is provided for 2020, as the base year 2021 and forecast through year-end 2027.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Antenna: Including Patch, Embedded, Fractal, Smart and Reflectors (IFT073G)
• Semiconductor Devices for High-Temperature Applications: Market Opportunities (SMC114B)
• Grid-Scale Electricity Storage Technologies: Global Markets (EGY142C)
• Global Lithium-ion Battery Market (FCB067A)
• Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market (BIO162C)